BETA-CASEIN A2 UND REDUZIERUNG ODER VORBEUGUNG VON SYMPTOMEN EINER LACTOSEINTOLERANZ

Patent europeic · EP3019180 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3019180
Numer da la dumonda
EP14823628
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-07-2014
Publitgà
18-05-2016
Concedì
29-05-2019
Stritgà
07-02-2024
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
A61K 35/20 (2006.01)
A61P 1/00 (2006.01)
A61K 38/17 (2006.01)
A61K 9/00 (2006.01)
A23L 33/19 (2016.01)
Prioritad
US 201361845480 P 12.07.2013
Dumonda PCT
PCT/NZ2014/000141 10.07.2014
Publicaziun PCT
WO2015/005804 15.01.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 07-02-2024

    Midada

    Published in Swissreg on 07.02.2024

  2. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  3. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  4. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

  5. 29-05-2019

    Concedì

    Published in Swissreg on 29.05.2019

Partidas

Possessur

The a2 Milk Company Limited

The A2 Milk Company Limited

Level 10 51 Shortland Street, Auckland 1010, NZ

Inventur

TRIVEDI, Malav Suchin

Hollywood, Florida 33020, US

CLARKE, Andrew John

Auckland, 1052, NZ

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.